Global Atorvastatin Calcium Sales Market Report 2020

Atorvastatin calcium is a pharmaceutical raw material in the production of atorvastatin calcium drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL cholesterol as well. Atorvastatin calcium usually is white powder and whose CAS number is 134523-03-8.
Atorvastatin calcium refers to a pharmaceutical raw material in the production of atorvastatin calcium drug. It contains chemical synthesis type and biocatalysis type. The atorvastatin calcium industry is a concentrated group relatively, as production qualification of atorvastatin calcium is controlled by government.

Market Analysis and Insights: Global Atorvastatin Calcium Market
The global Atorvastatin Calcium market size is projected to reach US$ 266.6 million by 2026, from US$ 188 million in 2020, at a CAGR of 6.0% during 2021-2026.

Global Atorvastatin Calcium Scope and Market Size
The global Atorvastatin Calcium market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Atorvastatin Calcium market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Atorvastatin Calcium market is segmented into
Chemical Synthesis
Biocatalysis
Others

Segment by Application, the Atorvastatin Calcium market is segmented into
Tablet (Including Dispersible Tablet and General Tablet)
Capsule
Others

The Atorvastatin Calcium market is analysed and market size information is provided by regions (countries). Segment by Application, the Atorvastatin Calcium market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape

and Atorvastatin Calcium Market Share Analysis
Atorvastatin Calcium market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Atorvastatin Calcium business, the date to enter into the Atorvastatin Calcium market, Atorvastatin Calcium product introduction, recent developments, etc.

The major vendors covered:
Pfizer
DSM Sinochem Pharmaceuticals
Cadila Pharmaceuticals
Sun Pharmaceutical Industries
Dr. Reddy’s
Morepen
Teva Pharmaceutical Industries
Apotex Pharmachem
Sandoz Inc
Mylan Pharmaceuticals Inc.
Kremers Urban Pharmaceuticals Inc.
ScieGen Pharmaceuticals, Inc.
Zheijang Neo-Dankon Pharmaceutical
Ningbo Menovo Pharmaceuticals Group
Jialin Pharmaceutical
Topfond
Zhejiang Hisun Pharmacutical
Zhejiang Hongyuan Pharmaceutical
Hubei Yitai Pharmaceutical
Jiangsu Hengrui Medicine